Mirum Pharmaceuticals, Inc. MIRM Conversion of convertible notes, net into shares of common stock
Conversion of convertible notes, net into shares of common stock at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept mirm:ConversionOfConvertibleNotesNet.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s conversion of convertible notes, net into shares of common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s conversion of convertible notes, net into shares of common stock?
- Mirum Pharmaceuticals, Inc. (MIRM) reported conversion of convertible notes, net into shares of common stock of $0 in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s conversion of convertible notes, net into shares of common stock changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s conversion of convertible notes, net into shares of common stock decreased by 100.0% year-over-year, from $6K to $0.
- What does conversion of convertible notes, net into shares of common stock mean?
- Measures the principal amount of convertible debt instruments that have been converted into equity shares during the reporting period. This activity reflects the deleveraging of the balance sheet and the resulting dilution of existing shareholders. It serves as an indicator of the company's capital structure evolution and the conversion behavior of debt holders based on equity performance.